Dr. Munir Ahmad
What this data tells you about Dr. Ahmad
Dr. Munir Ahmad is a hematology & oncology in Lufkin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ahmad performed 47,821 Medicare services across 1,635 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahmad received a total of $3,154 from 36 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 23,970 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $18 | $55 |
| Epoetin alfa injection (Retacrit) for anemia | 4,820 | $6 | $45 |
| Iron sucrose injection (Venofer) | 4,500 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 2,301 | $0 | $1 |
| Dexamethasone injection (steroid) | 1,420 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 930 | $1 | $51 |
| Blood draw (venipuncture) | 904 | $8 | $25 |
| Complete blood count (CBC) with differential | 884 | $8 | $65 |
| Office visit, established patient (30-39 min) | 360 | $95 | $350 |
| Injection of additional new drug or substance into vein | 297 | $12 | $80 |
| Office visit, established patient (20-29 min) | 266 | $65 | $250 |
| Administration of chemotherapy into vein, 1 hour or less | 207 | $100 | $550 |
| Drug injection, under skin or into muscle | 206 | $11 | $65 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 203 | $22 | $205 |
| Administration of chemotherapy into vein, each additional hour | 179 | $22 | $225 |
| Irrigation of implanted venous access drug delivery device | 124 | $18 | $250 |
| Injection, diphenhydramine hcl, up to 50 mg | 83 | $1 | $15 |
| Advance care planning consultation, first 30 min | 77 | $56 | $145 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 71 | $48 | $250 |
| Administration of additional new drug or substance into vein, 1 hour or less | 61 | $50 | $275 |
| New patient office visit (45-59 min) | 61 | $117 | $475 |
| Infusion into a vein for hydration, each additional hour | 53 | $10 | $110 |
| Blood glucose (sugar) measurement using reagent strip | 51 | $5 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 51 | $3 | $10 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 50 | $1,164 | $7,122 |
| Unclassified drugs | 50 | $1 | $48 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 48 | $128 | $650 |
| Infusion, normal saline solution, 250 cc | 47 | $0 | $22 |
| Office visit, established patient, complex (40-54 min) | 43 | $133 | $450 |
| Chronic care management, first 20 min/month | 33 | $22 | $85 |
| Infusion, normal saline solution , 1000 cc | 26 | $2 | $25 |
| Drawing of blood for a medical problem | 25 | $69 | $250 |
| Ct scan of chest with contrast | 24 | $73 | $1,140 |
| CT scan of abdomen and pelvis with contrast | 24 | $220 | $1,800 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $26 | $130 |
| CT scan of chest, without contrast | 12 | $101 | $900 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ahmad is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmad experienced with iron infusion (feraheme)?
Does Dr. Ahmad receive payments from pharmaceutical companies?
How do Dr. Ahmad's costs compare to other hematology & oncologys in Lufkin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology